General Information of This Metabolic Reaction (MR) (ID: MR006439)
Formula Reactant RSD-1235 Product RSD-1390
Reactant Info Product Info
Metabolic Type Oxidation - 3-O-demethylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006438 RSD-1235 RSD-1385 Oxidation - 4-O-demethylation RSD-1235 [1]
References
1 Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors. J Clin Pharmacol. 2009 Jan;49(1):17-29.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.